{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:04:21Z","timestamp":1779905061488,"version":"3.53.1"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,5,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence and pattern of endocrinopathy in patients with cancer pain receiving long-term opioid therapy and evaluate the associated temporal hormonal changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This prospective, hospital-based observational study was conducted in a tertiary care centre in India and included 175 patients with histologically confirmed cancer (\u226518 years) receiving oral daily morphine of \u226525\u2009mg for at least 3\u2009months. Serum levels of testosterone, thyroid-stimulating hormone (TSH), thyroxine, adrenocorticotropic hormone (ACTH), follicle-stimulating hormone (FSH), luteinising hormone (LH), growth hormone (GH), estradiol and prolactin were assessed at baseline and week 12. Data were analysed using repeated-measures analysis of variance with Bonferroni post hoc correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most participants were middle-aged males (mean age, 46.96\u00b19.30 years) with advanced-stage cancer (64.6%). Significant hormonal alterations were observed over the 12-week period (p&lt;0.001). Mean testosterone levels decreased from 2.49\u00b11.76\u2009ng\/mL at baseline to 2.01\u00b11.42\u2009ng\/mL at week 12, T4 declined from 1.30 \u00b1 0.24 to 1.05 \u00b1 0.19 pg\/mL, ACTH from 31.41 \u00b1 18.58 to 25.36 \u00b1 15.01 pg\/mL and prolactin rose from 11.06 \u00b1 4.22 to 13.35 \u00b1 5.10 ng\/mL. Similar downward trends were noted for FSH, LH, GH and estradiol, whereas TSH increased from 2.12 \u00b1 1.09 to 2.57 \u00b1 1.32 \u00b5IU\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Chronic opioid therapy is associated with substantial suppression of gonadal, adrenal and thyroid axes and elevation of prolactin levels, consistent with opioid-induced endocrinopathy. Regular endocrinological assessment should be integrated into palliative care to improve quality of life in patients with cancer receiving long-term opioid therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-006010","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:20:16Z","timestamp":1779902416000},"page":"spcare-2025-006010","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Endocrinopathy in patients with cancer pain on opioids: prospective observational study"],"prefix":"10.1136","author":[{"given":"Ashwin","family":"Mathur","sequence":"first","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-4797","authenticated-orcid":false,"given":"Pavan","family":"Gaurav R","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2026052710201009000_spcare-2025-006010v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.12.340"},{"key":"2026052710201009000_spcare-2025-006010v1.2","unstructured":"World Health Organization . Cancer pain relief: with a guide to opioid availability. 2nd edn. Geneva: WHO, 1996."},{"key":"2026052710201009000_spcare-2025-006010v1.3","first-page":"20","article-title":"Opioid-induced endocrinopathy","volume":"109","author":"Colameco","year":"2009","journal-title":"J Am Osteopath Assoc"},{"key":"2026052710201009000_spcare-2025-006010v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.12.001"},{"key":"2026052710201009000_spcare-2025-006010v1.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2215"},{"key":"2026052710201009000_spcare-2025-006010v1.6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(25)31003-7","article-title":"Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males","volume":"202","author":"Mendelson","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"2026052710201009000_spcare-2025-006010v1.7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0009"},{"key":"2026052710201009000_spcare-2025-006010v1.8","doi-asserted-by":"crossref","unstructured":"Aloisi AM , Ceccarelli I . Gonadal hormones and pain modulation. In: Buonocore G , Bellieni CV , eds. Neonatal Pain. Springer, Milano, 2008. Available: https:\/\/doi.org\/10.1007\/978-88-470-0732-1_2","DOI":"10.1007\/978-88-470-0732-1_2"},{"key":"2026052710201009000_spcare-2025-006010v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31827c7b5d"},{"key":"2026052710201009000_spcare-2025-006010v1.10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jpainsymman.2010.06.021","article-title":"Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced Cancer","volume":"41","author":"Dev","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"2026052710201009000_spcare-2025-006010v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20028"},{"key":"2026052710201009000_spcare-2025-006010v1.12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(25)38343-6","article-title":"Opioid-induced suppression of rat testicular function","volume":"266","author":"Adams","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"2026052710201009000_spcare-2025-006010v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532387"},{"key":"2026052710201009000_spcare-2025-006010v1.14","doi-asserted-by":"publisher","DOI":"10.1054\/jpai.2002.126790"},{"key":"2026052710201009000_spcare-2025-006010v1.15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00019616-200201000-00002","article-title":"Low-Serum Cortisol Associated With Opioid Use: Case Report and Review of the Literature","volume":"12","author":"Lee","year":"2002","journal-title":"Endocrinologist"},{"key":"2026052710201009000_spcare-2025-006010v1.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01483.x"},{"key":"2026052710201009000_spcare-2025-006010v1.17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/etm.2016.3156","article-title":"Opioid endocrinopathy: A clinical problem in patients with cancer pain","volume":"11","author":"Merdin","year":"2016","journal-title":"Exp Ther Med"},{"key":"2026052710201009000_spcare-2025-006010v1.18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1202851"},{"key":"2026052710201009000_spcare-2025-006010v1.19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mayocpiqo.2019.06.007","article-title":"Opioid-Induced Hypogonadism in the United States","volume":"3","author":"Baillargeon","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2026052710201009000_spcare-2025-006010v1.20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks and management of opioid-related endocrine dysfunction","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad Med"},{"key":"2026052710201009000_spcare-2025-006010v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2005.12.002"},{"key":"2026052710201009000_spcare-2025-006010v1.22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2213-8587(19)30254-2","article-title":"Opioid-induced endocrinopathies","volume":"8","author":"Fountas","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026052710201009000_spcare-2025-006010v1.23","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181d1059d"},{"key":"2026052710201009000_spcare-2025-006010v1.24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0091-3057(80)90431-1","article-title":"Effects of heroin and naltrexone on plasma prolactin levels in man","volume":"12","author":"Ellingboe","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"2026052710201009000_spcare-2025-006010v1.25","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1076715"},{"key":"2026052710201009000_spcare-2025-006010v1.26","doi-asserted-by":"crossref","first-page":"ES145","DOI":"10.36076\/ppj.2012\/15\/ES145","article-title":"Opioid-Induced Androgen Deficiency (OPIAD)","volume":"3S;15","author":"Elliott","year":"2012","journal-title":"Pain Phys"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-006010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:20:19Z","timestamp":1779902419000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":26,"alternative-id":["10.1136\/spcare-2025-006010"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-006010","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}